192 related articles for article (PubMed ID: 31296924)
1. Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13.
Creyns B; Cremer J; Hoshino T; Geboes K; de Hertogh G; Ferrante M; Vermeire S; Ceuppens JL; Van Assche G; Breynaert C
Sci Rep; 2019 Jul; 9(1):10064. PubMed ID: 31296924
[TBL] [Abstract][Full Text] [Related]
2. Yogurt starter cultures of Streptococcus thermophilus and Lactobacillus bulgaricus ameliorate symptoms and modulate the immune response in a mouse model of dextran sulfate sodium-induced colitis.
Wasilewska E; Zlotkowska D; Wroblewska B
J Dairy Sci; 2019 Jan; 102(1):37-53. PubMed ID: 30343915
[TBL] [Abstract][Full Text] [Related]
3. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses.
Sang LX; Chang B; Zhu JF; Yang FL; Li Y; Jiang XF; Wang DN; Lu CL; Sun X
World J Gastroenterol; 2017 Jun; 23(21):3850-3863. PubMed ID: 28638225
[TBL] [Abstract][Full Text] [Related]
4. Sodium chloride exacerbates dextran sulfate sodium-induced colitis by tuning proinflammatory and antiinflammatory lamina propria mononuclear cells through p38/MAPK pathway in mice.
Guo HX; Ye N; Yan P; Qiu MY; Zhang J; Shen ZG; He HY; Tian ZQ; Li HL; Li JT
World J Gastroenterol; 2018 Apr; 24(16):1779-1794. PubMed ID: 29713131
[TBL] [Abstract][Full Text] [Related]
5. Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F.
Zhou C; Wu D; Jawale C; Li Y; Biswas PS; McGeachy MJ; Gaffen SL
Cytokine; 2021 Dec; 148():155715. PubMed ID: 34587561
[TBL] [Abstract][Full Text] [Related]
6. IL-33 induces both regulatory B cells and regulatory T cells in dextran sulfate sodium-induced colitis.
Zhu J; Xu Y; Zhu C; Zhao J; Meng X; Chen S; Wang T; Li X; Zhang L; Lu C; Liu H; Sun X
Int Immunopharmacol; 2017 May; 46():38-47. PubMed ID: 28258042
[TBL] [Abstract][Full Text] [Related]
7. IL-33 Protects Mice against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses as Well as Decreasing Th17 Cell Response.
Zhu JF; Xu Y; Zhao J; Li X; Meng X; Wang TQ; Zou BY; Zhao PY; Liu Q; Lu CL; Zheng FL; Liu HS
J Immunol Res; 2018; 2018():1827901. PubMed ID: 30539029
[TBL] [Abstract][Full Text] [Related]
8. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.
Wedebye Schmidt EG; Larsen HL; Kristensen NN; Poulsen SS; Lynge Pedersen AM; Claesson MH; Pedersen AE
Inflamm Bowel Dis; 2013 Jul; 19(8):1567-76. PubMed ID: 23689808
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.
Jauch D; Martin M; Schiechl G; Kesselring R; Schlitt HJ; Geissler EK; Fichtner-Feigl S
Gut; 2011 Dec; 60(12):1678-86. PubMed ID: 21948944
[TBL] [Abstract][Full Text] [Related]
10. Perilla frutescens extract ameliorates DSS-induced colitis by suppressing proinflammatory cytokines and inducing anti-inflammatory cytokines.
Urushima H; Nishimura J; Mizushima T; Hayashi N; Maeda K; Ito T
Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(1):G32-41. PubMed ID: 25359539
[TBL] [Abstract][Full Text] [Related]
11. Role of innate lymphoid cells in chronic colitis during anti-IL-17A therapy.
Park CH; Lee AR; Ahn SB; Eun CS; Han DS
Sci Rep; 2020 Jan; 10(1):297. PubMed ID: 31941937
[TBL] [Abstract][Full Text] [Related]
12. Disruption of Tumor Necrosis Factor Receptor-Associated Factor 5 Exacerbates Murine Experimental Colitis via Regulating T Helper Cell-Mediated Inflammation.
Shang J; Li L; Wang X; Pan H; Liu S; He R; Li J; Zhao Q
Mediators Inflamm; 2016; 2016():9453745. PubMed ID: 27110068
[TBL] [Abstract][Full Text] [Related]
13. Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice.
Zhang B; Liu Y; Lan X; Xu X; Zhang X; Li X; Zhao Y; Li G; Du C; Lu S; Wang H
J Transl Med; 2018 Mar; 16(1):71. PubMed ID: 29554971
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice.
Yoshihara K; Yajima T; Kubo C; Yoshikai Y
Gut; 2006 Mar; 55(3):334-41. PubMed ID: 16162679
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
16. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
[TBL] [Abstract][Full Text] [Related]
19. Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice.
Dunkin D; Berin MC; Mondoulet L; Tobar S; Yeretssian G; Tordesillas L; Iuga A; Larcher T; Gillespie V; Benhamou PH; Colombel JF; Sampson HA
Inflamm Bowel Dis; 2017 Nov; 23(11):1972-1982. PubMed ID: 29019858
[TBL] [Abstract][Full Text] [Related]
20. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
